2m 2m 2m 2m 2m 2m 2m
BIOAGE LABS (BIOA)
NASDAQ
$9.67+$0.19 (+2.00%)
Price as of Aug 21, 2026 7:34 PM EDT- $435.1MMarket Cap
- 105.64%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
BIOAGE LABS (BIOA)
$9.67+$0.19 (+2.00%)
BIOA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.48 | ||
Change | -$0.21 (-2.17%) | ||
Open | $9.78 | ||
High | $9.92 | ||
Low | $9.48 | ||
Previous Close | $9.69 | ||
Volume | 453,445 | ||
30-Day Average Volume | 1,290,037 | ||
1-Week Change | -10.57% | ||
1-Month Change | -58.15% | ||
1-Year Change | 105.64% | ||
3-Year Change | 5,828.71% | ||
5-Year Change | 5,828.71% | ||
Fundamentals | |||
Shares Outstanding | 45.9M | ||
Total Assets | $396.9M | ||
Market Cap | $435.1M | ||
Enterprise Value | $361.1M | ||
Period: QTR TTM FY | |||
Revenue | $2.5M | ||
Net Income | -$26.1M | ||
Free Cash Flow | -$19.6M | ||
EBIT | -$26.1M | ||
EBITDA | -$26.1M | ||
Net Working Capital | $311.1M | ||
EPS | -$0.58 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | 147 | ||
P/B | 1 | ||
P/E | -16 | ||
PEG | 1 | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue